Molecular identification and characterization of rifampicin-resistantMycobacterium tuberculosisisolates by line probe assay: an approach for rapid diagnosis of multidrug-resistant tuberculosis
Authors:
Open Access
- 1 September 2008
- journal article
- Published by Wiley in Letters in Applied Microbiology
- Vol. 47 (3) , 214-220
Abstract
Early identification and characterization of rifampicin-resistant (R(r)) Mycobacterium tuberculosis isolates recovered from the samples of tuberculosis (TB) patients in the Aegean (West Anatolian) Region was intended. Sixty isolates [47 (78.3%) multidrug-resistant (MDR)], which were identified as M. tuberculosis complex and phenotypically resistant to rifampicin by both BACTEC mycobacteria growth indicator tube (MGIT) 960 and 460 systems were analysed by a commercial line probe assay (INNO-LiPA Rif TB). The concordance of LiPA with the in vitro susceptibility test was found as 98.3%. Among the isolates, S531L (R5 pattern; 46.7%) and L511P/R, S512T, Q513L/K (DeltaS1 pattern; 11.7%) were the most frequent mutation patterns. As compared with the BACTEC systems and conventional techniques for cultivation, identification and in vitro susceptibility testing, INNO-LiPA Rif TB after cultivation in BACTEC MGIT 960 system provided an average of 20 days early diagnosis of R(r)M. tuberculosis isolates. Rapid molecular identification and characterization of R(r)M. tuberculosis isolates after BACTEC MGIT 960 cultivation would be useful for faster diagnosis, infection control and planning of accurate treatment in MDR-TB patients. Patients with MDR-TB need a specified treatment and efficient follow-up strategies. Rapid and practical methodologies to diagnose and follow these patients should be applied in routine use.Keywords
This publication has 19 references indexed in Scilit:
- The clinical management of drug-resistant tuberculosisCurrent Opinion in Pulmonary Medicine, 2007
- Evaluation of the Genotype MTBDR Assay for Rapid Detection of Rifampin and Isoniazid Resistance in Mycobacterium tuberculosis IsolatesJournal of Clinical Microbiology, 2006
- Evaluation of the line probe assay (LiPA) for rapid detection of rifampicin resistance in Mycobacterium tuberculosisTuberculosis, 2004
- Characterization of rpoB Mutations in Rifampin-Resistant Clinical Isolates of Mycobacterium tuberculosis from Turkey by DNA Sequencing and Line Probe AssayJournal of Clinical Microbiology, 2002
- Molecular Characterization of Rifampin-Resistant Isolates of Mycobacterium tuberculosis from Hungary by DNA Sequencing and the Line Probe AssayJournal of Clinical Microbiology, 2001
- Characterization of rpoB mutations in rifampin-resistant Mycobacterium tuberculosis isolates from the Middle EastDiagnostic Microbiology and Infectious Disease, 2000
- A clinical, microbiological and economic analysis of a national service for the rapid molecular diagnosis of tuberculosis and rifampicin resistance in Mycobacterium tuberculosisJournal of Medical Microbiology, 2000
- Molecular analysis of rifampin and isoniazid resistance of Mycobacterium tuberculosis clinical isolates in Seville, SpainTubercle and Lung Disease, 1999
- Rapid detection of multidrug-resistant tuberculosisEuropean Respiratory Journal, 1997
- Mutation position and type of substitution in the β-subunit of the RNA polymerase influence in-vitro activity of rifamycins in rifampicin-resistant Mycobacterium tuberculosisJournal of Antimicrobial Chemotherapy, 1995